Chuo-ku

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Head and neck cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 12 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Eisai Co., Ltd.2 trials

Closed trials

• Completed

  A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

  NCT04572295· Phase 1· Eisai Co., Ltd.· Source

• Terminated

  A Study of E7130 in Participants With Solid Tumors

  NCT03444701· Phase 1· Eisai Co., Ltd.· Source